Streetwise Reports' Article Archives — December 2019 back to current month (127)
Firm Announces Contract to Supply Oil to Peru-Owned Company (12/31/2019)
It will produce the oil to be sold at its flagship asset in the Maranon Basin.
Copper Firm Recaps Encouraging Results from 2019 Exploration (12/31/2019)
The company's successes in this regard align with its aim to capitalize on its organic growth and land position.
Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device (12/31/2019)
Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina.
Beware the Stock Market (12/31/2019)
Sector expert Bob Moriarty takes a look at drivers in the bull market and sees a bear in the wings.
Savara Shares Double After FDA Grants Breakthrough Therapy Status for aPAP Treatment (12/30/2019)
Shares of Savara opened nearly 140% higher today after the orphan lung disease company advised that the FDA has granted Breakthrough Therapy designation for the firm's Molgradex for treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
Basel III and Bailouts: What Do They Mean for the Markets? (12/30/2019)
Maurice Jackson of Proven and Probable interviews Andy Schectman of Miles Franklin Precious Metals Investments about the implications of monetary policies being implemented by central banks worldwide, and about the state of the U.S. economy.
Gold Market Update: Metal Up, Dollar Down (12/30/2019)
Technical expert Clive Maund charts the reasons the precious metals have entered a bull market.
Silver Market Update: A Bullish Setup in Place (12/30/2019)
Technical analyst Clive Maund charts the end-of-the-year status of the silver market.
A Short Update on Irving, Lion One and Novo (12/29/2019)
Bob Moriarty of 321gold unwraps the people and projects he believes makes these companies compelling investments.
Resource Update on Canadian Gold Property Due Early Q1/20 (12/27/2019)
The status and review of a few aspects of this project are provided in a Canaccord Genuity report.
Biotech Advances Imaging Product to Functional Development Phase (12/27/2019)
The company aims to conduct pilot production testing in Q1/20.
Iterum Therapeutics Shares Double After Completing Enrollment in Phase 3 Antibiotic Trial (12/27/2019)
Iterum Therapeutics shares traded more than 100% higher after the company reported that it has completed enrollment in its Phase 3 SURE 1 clinical study of oral sulopenem for treatment of uncomplicated urinary tract infections. The firm expects to receive topline data results in Q1/20.
Biopharma Continues 'Positive Push Forward in Breast Cancer' (12/27/2019)
The latest clinical trial results and next step are reviewed in an H.C. Wainwright & Co. report.
Pre-Commissioning at Argentina Gold Project Expected in January (12/27/2019)
Mine operations and preproduction work continue nonstop, the company stated.
Company to Continue Exploration at Ontario Property Contiguous with High-Profile Project (12/27/2019)
The Canadian junior will stay focused on two primary targets.
The Ins and Outs of Making a Private Placement (12/27/2019)
In part two of his series, 'All About Private Placements,' Maurice Jackson of Proven and Probable solicits details on how to find private placements, and then how to process forms for those placements, from Tekoa Da Silva, a financial advisor with Sprott USA.
Initial Deep Drill Results from Fiji Gold Project 'Positive' (12/26/2019)
The assays are presented and reviewed in an Echelon Wealth Partners report.
Target Price Raised on Gold Company Post Feasibility Study Release (12/26/2019)
Highlights of that document and the mine ramp-up are presented in a BMO Capital Markets report.
Ellomay Capital Shares Get a Spark from 265 MW Italian Photovoltaic Development Projects (12/26/2019)
Shares of Israel-based renewable energy firm Ellomay Capital got a jolt today after the firm released details of the development plans for photovoltaic projects in Italy with aggregate capacity of 265 megawatts.
Analyst: Acquisition Accretive for Oklahoma Energy Company (12/24/2019)
The favorable metrics of the transaction are discussed in a Raymond James report.
'Well-Planned, Accretive Acquisition' of Leagold Moves Equinox to Mid-Tier Status (12/24/2019)
The highlights and benefits of the transaction are provided in a Haywood report.
Exploration Firm Returns 'More Positive Assay Results' at Quebec Project (12/24/2019)
The latest findings are reviewed in an Echelon Wealth Partners report.
Microbot Shares Soar on Claims It Has Created the World's First Fully Disposable Endovascular Robotic System (12/24/2019)
Shares of Microbot Medical traded 70% higher after the company reported that in January 2020 it will unveil the world's first fully disposable robotic system for endovascular procedures. The firm claims that its breakthrough technology features compact design, remote operation capabilities and an integrated "One & Done" tool to democratize endovascular procedures.
Canadian Explorer Options Gold Property in Red Lake District (12/24/2019)
For full ownership, the earn-in period is two years.
Coverage Initiated on Immunotherapies Developer with 'Catalyst Rich 2020' (12/23/2019)
The key business and investment points are presented in a ROTH Capital Partners report.
Fracking Imminent for Orogrande Basin Well (12/23/2019)
The purpose is to show its potential for commercial oil production.
Online AR Experiences Now Possible Via Facebook Messenger (12/23/2019)
This achievement represents another step toward making augmented reality technology universally accessible.
Equity Metals Brings Fresh Eyes to Silver Queen's Resources (12/23/2019)
Thibaut Lepouttre of Caesars Report examines how this Canadian company intends to improve on the 440,000-ounce gold-equivalent resource at its flagship project.
Azarga Gets Thumbs Up from Analysts After Favorable Ruling on NRC License (12/23/2019)
After receiving a favorable ruling on the NRC license, its focus shifts to project economics.
Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug (12/23/2019)
Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTAŽ (lumateperone) drug for the treatment of schizophrenia in adults.
Apache and Total Form $5 Billion Joint Venture to Drill off Suriname Coast (12/23/2019)
Shares of Apache Corp. traded 16% higher today after the company reported that it has formed a joint venture with Total SA of France to explore and develop Block 58 offshore Suriname.
Healthcare Innovator to Acquire Canadian Telehealth Firm (12/21/2019)
The purchase price for the company is 4.5 million shares.
Explorer Plans Drill Program for Ontario Red Lake Project (12/21/2019)
The company will start the work there in either late winter or early spring 2020.
Firm Signs Four Agreements for Nevada Properties, Sells Water Rights (12/21/2019)
Agreements are for one lease, one option and two sales deals.
Telehealth Firm Starts Pilot with Australian Aeromedical Agency (12/21/2019)
The program goal is to improve care access and health outcomes among residents of Australia's remote and rural areas.
Nevada Miner Reaches Milestone as Production Begins (12/21/2019)
Maurice Jackson of Proven and Probable discusses future plans with this copper company's senior VP of Operations.
NewLink Genetics Shares Shoot Higher after FDA Ebola Vaccine Approval (12/20/2019)
Shares of NewLink Genetics got a boost today after the firm reported that the FDA approved its ERVEBO V920 vaccine used in the treatment of Zaire Ebola virus. The company's shares set a new 52-week high price in mid-morning trading.
GFG Waits for Barn-Burning News (12/20/2019)
Bob Moriarty of 321gold provides an update on this junior miner.
One-Week Sale on Aurania Shares (12/20/2019)
Bob Moriarty of 321gold describes the investment opportunity in this company.
Los Angeles Football Club to Pilot Firm's Covert Threat Detection Platform (12/19/2019)
The developer will initially deploy its product at Banc of California stadium in January.
Mining Company Identifies Four New Targets at Massive BC Asset (12/19/2019)
The firm states the new targets could "contribute to the multi-generational life" of the district.
Explorer Hits High-Grade Gold Intercepts at Fiji Project (12/19/2019)
The results suggest possible geologic scenarios that require further testing.
Explorer Confirms Presence of Polymetallic System at Montana Target (12/19/2019)
Mineralization demonstrated there consists of platinum group elements, nickel, copper and cobalt.
Two Gold Firms Agree to Nevada Asset Sale Transaction (12/19/2019)
The explorer is to sell its net profit interest in a Nevada property to a royalty company.
Royalties Face Mine Problems and Tax Bills (12/19/2019)
Money manager Adrian Day looks at two top royalty companies, both with a changing of the guard at the top, both with other important developments, plus he lists some companies he sees as buys.
Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax (12/19/2019)
Shares of Paratek Pharmaceuticals traded 40% higher today after the firm announced it was awarded a BARDA BioShield program contract valued at up to $285 million for NUZYRA used to treat anthrax.
Agreement Sets Stage to Secure Chinese Approval of Non-Antibiotic Livestock Feed Supplement (12/18/2019)
The requirements include, among others, trials of the company's livestock feed additive.
DSI Says Palladium Approaching a Sell, and DSI Is on Sale (12/18/2019)
Bob Moriarty of 321gold takes a look at the Daily Sentiment Index for palladium.
Syros Pharma Teams Up with Global Blood Therapeutics to Fight Sickle Cell Disease (12/18/2019)
Syros Pharmaceuticals' shares rose 20% today after the firm reported that it entered into a collaboration agreement with Global Blood Therapeutics for development of therapies for sickle cell disease and beta thalassemia that could result in payments to Syros as high as $315 million over three years.
The Critical Investor Interviews Joe Grosso, CEO of Golden Arrow Resources (12/18/2019)
The Critical Investor sits down with Joe Grosso, CEO of Golden Arrow Resources, to discuss the company's exploration plans for the new year.
Biopharma to Test Immunity Activator in Advanced Solid Cancers (12/17/2019)
The company's plans for and approach to one of its most advanced drug candidates are discussed in an H.C. Wainwright & Co. report.
Biopharma 'Keeps Executing and Securing Milestones' (12/17/2019)
The company's latest achievement and partnership potential are addressed in a ROTH Capital Partners report.
News Flash! (12/17/2019)
Sector expert Michael Ballanger asserts that statements by American financial and political leaders are little more than market manipulations.
Colorado Vanadium/Uranium Project Now Production Ready (12/17/2019)
The firm is finishing state mining agency requirements, targeting completion of those by end of January 2020.
Miner Starts IP Survey on Nevada Project (12/17/2019)
The company states the aim is to better define the gold trend.
Delivery Tech Firm Generates Record Revenue in November (12/17/2019)
The Canadian company attributes this achievement to increased sales in each of its business segments.
Feed Additive Developer Signs MOU with Philippine Distributor (12/17/2019)
This is the first step toward a binding, definitive agreement between the two companies.
Augmented Reality Firm Lands First Deal in Medical Device Market (12/17/2019)
The new customer intends to use two of the company's platforms for marketing and education purposes.
Tallgrass Energy Shares Rise 20% on Blackstone Partners Acquisition Deal (12/17/2019)
Shares of Tallgrass Energy LP traded 20% higher after the firm advised that it entered into a definitive merger agreement with Blackstone Infrastructure Partners to acquire all of the company's publicly held outstanding class A shares for $22.45 per share in cash.
Explorer's Latest Red Lake Drill Results Include New Zone, Best Assay (12/17/2019)
These findings are from the ongoing 200,000m drill testing at its Ontario project.
Nevada Copper Delivers Copper Now (12/17/2019)
Bob Moriarty of 321gold discusses recent copper price moves along with those of a new copper producer.
Two Canadian Gold Projects 'Show the High Grades,' Expansion Potential (12/16/2019)
Recent drill results from both assets are provided in a ROTH Capital Partners report.
Digital Marketing Tech Firm Releases Growth Strategies for 2020 (12/16/2019)
The company has announced two new initiatives to propel growth.
Major Firearms Distributor Adopts Firm's Augmented Reality Technology (12/16/2019)
This development is part of the company's recently expanded contract with Walther.
Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome (12/16/2019)
Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application filing in H2/20.
Prospect Generator Preparing Ontario Gold Project for 2020 (12/16/2019)
Maurice Jackson of Proven and Probable speaks with Dr. John-Mark Staude, CEO of Riverside Resources, about his company's recent exploration efforts at its Oakes gold project in Ontario and what lies ahead in the new year.
REE Project's Final Drill Results Show Expansion Potential (12/15/2019)
The company reports the assays for its campaign's last two drill holes for its Canadian REE project.
Animal Health Product Developer Lands First Sale in Malaysia (12/15/2019)
The maiden order comes on the heels of the country approving use of the product there.
Supplier Enters Canadian Recreational Cannabis Market (12/13/2019)
The Vancouver-based company debuts its premium brand dried flower in Alberta.
Firm to Launch 3D Augmented Reality Capture App (12/13/2019)
Anyone with the product and a smartphone will be able to create 3D models of 2D objects.
Company Plans Yukon Exploration as Copper Price Predicted to Rise (12/13/2019)
Tim Johnson, CEO of Granite Creek Copper, sits down with Maurice Jackson of Proven and Probable to discuss the copper market, his company's exploration plans in the Yukon and its recent purchase of a 30% stake in its neighbor.
Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug (12/13/2019)
Sarepta Therapeutics shares traded 35% higher after the firm reported that the FDA approved its second RNA exon-skipping treatment drug VYONDYS 53 injection for the treatment of Duchenne's Muscular Dystrophy in patients amenable to skipping Exon 53.
STACK Agreement 'Positive' for Area Operator (12/12/2019)
The deal details are relayed in a ROTH Capital Partners report.
Technical Analyst: Gold's Downtrend Has Further to Run (12/12/2019)
Technical analyst Clive Maund looks at recent moves in gold and their correlation to the dollar.
Silver Remains in 'Corrective Downtrend' (12/12/2019)
Technical analyst Clive Maund charts the longer term picture for silver.
Assertio Therapeutics' Shares Jump 50% on Sale of Shingles Pain Drug to Alvogen (12/12/2019)
Assertio Therapeutics' shares rose 50% today after the firm reported that it has agreed to sell all rights to its Gralise drug used in the treatment of pain from shingles to Alvogen for $127.5 million. The transaction is expected to close in January 2020.
Defense Metals Offers Cheapest Call on Rare Earths and Brilliant Drill Holes (12/12/2019)
Bob Moriarty of 321gold looks at the LREO explorer's drill results at its Canadian project.
Company Signs Earn-in Agreement with MATSA, Eyes Gold Projects (12/11/2019)
The Critical Investor sits down with Avrupa Minerals CEO Paul Kuhn to discuss plans for the company's Alvalade project in Portugal in light of the recent earn-in agreement with Mubadala Investment Company and Trafigura.
Royalty Firm to Sell Nevada Asset (12/11/2019)
The consideration for the project is $250,000 in cash and a 2% net smelter return royalty on the claims.
Recruiter.com Doubles Network Membership Since July (12/11/2019)
The company expects to continue this growth in the near term.
Augmented Reality Pure Play Lands First Customer in New Vertical (12/11/2019)
This development aligns with the firm's goal of dominating key multibillion dollar business segments.
Oil & Gas Producer Doubles Share Buyback Program to $50 Million, Increases Guidance (12/11/2019)
Recent company announcements are discussed in a Pareto Securities report.
Coverage Initiated on Mining Triple Threat: Explorer, Developer, Producer (12/11/2019)
The basis of Haywood's investment thesis for this Canadian company is shared in a recent report.
Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research (12/11/2019)
Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-2020, and potential for a Marketing Authorization Application in 2021.
Petroleum Firm Sells Assets to Focus on Montney Projects (12/11/2019)
The details, finances and impact of the transaction are discussed in a CIBC report.
A.I.S. Resources: A New Gold Prospect + Manganese Trading + Li Extraction Technology (12/11/2019)
Peter Epstein of Epstein Research profiles a company that is reinventing itself as moderately diversified battery metals company.
Company Extends REE Mineralization at Canada Project (12/10/2019)
Consequently, additional drill testing is warranted in the specific host zone.
Oil & Gas Firm Provides Update on Exploration Well (12/10/2019)
Drill testing leads to decision to abandon the well.
Silver: The HARD Look (12/10/2019)
Precious metals expert Michael Ballanger takes a look at the factors behind silver's recent price decline.
Avid Bioservices' Shares Rise on Q2/20 Earnings and Confirmed Outlook (12/10/2019)
Shares of Avid Bioservices traded higher today, reaching a new 52-week high, after the firm reported Q2/20 earnings and reaffirmed its revenue guidance for Full-Year 2020.
Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's (12/10/2019)
How this company's Alzheimer's therapeutic compares to an advanced-stage competitor is outlined in a Dawson James Securities note.
Copper Company Closes 30% Share of Acquisition of Copper North Mining (12/09/2019)
The two companies are advancing adjoining projects in the Yukon.
ArQule Shares Double on Proposed $2.7 Billion Tender Offer from Merck (12/09/2019)
ArQule Inc. shares traded more than 100% higher today after the company entered into definitive agreement to be acquired by a Merck subsidiary company for $20 per share. The deal is valued at $2.7 billion and is expected to close in the early part of Q1/20.
Young Company Plans to Bring Mexican Gold Deposit to Market in Two Years (12/09/2019)
Andrew Bowering, president of Prime Mining, talks with Maurice Jackson of Proven and Probable about his company's plans to fast track its gold project.
Company Reports 'Robust PEA' for South Dakota Uranium Project (12/07/2019)
The report validates the Colorado-based company's strategy.
Antibiotic Alternative for Livestock Feed Approved for Malaysia (12/07/2019)
Now, the company has the green light to sell this product in eight countries.
Explorer More Than Doubles Drill Campaign at Red Lake District Project (12/07/2019)
The Canadian company announced a $21 million budget and aims to complete the expansion by year-end 2020.
Explorer Gathers Data on Quebec Gold Property (12/06/2019)
Regional geology, mineral showings, historical drill results and magnetic survey results are among the information obtained.
Explorer Options Majority Interest in Gold Project (12/06/2019)
Incubating and monetizing assets are among the company's strategic objectives.
'High Potential' Targets Identified at Oaxaca Gold Project (12/06/2019)
The gold-silver company continues to advance the asset.
Imagin Medical Poised for Breakout with Bladder Cancer Detection Device (12/06/2019)
A new advancement in bladder-related endoscopic surgery is endorsed and de-risked.
Cassava Sciences' Shares Trade Up 20% on Updated Phase 2a Alzheimer's Data (12/06/2019)
Shares of Cassava Sciences traded 20% higher after the firm presented additional data from the Phase 2a study of its investigational drug candidate PTI-125 for Alzheimer's disease to the Clinical Trials on Alzheimer's Disease conference in San Diego, Calif.
'Huge Upside Potential' on Firm That Turns Plastic Waste into Synthetic Fuels (12/05/2019)
The rationale for investing in this company is provided in a Pareto Securities report.
Junior Explorer Moves Forward in 'Prime Gold Real Estate' (12/05/2019)
Jay Taylor of J. Taylor's Gold, Energy & Tech Stocks examines the prospects of a company working in the exploration and development of Larder gold deposits along the Cadillac-Larder Lake Fault in Ontario.
AR Tech Company Expands Deal with Manufacturer of James Bond PPK (12/05/2019)
The firm will now provide its Web-based, three-dimensional, augmented reality service to the client.
Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data (12/05/2019)
Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20.
Immuno-Oncology Firm Expands Agreement with AbbVie (12/04/2019)
The revisions to the existing arrangement between the two U.S. firms are discussed in a ROTH Capital Partners report.
Bitumen Resource Estimate Completed for Alberta Asset (12/04/2019)
The report outlines a development plan for the project.
Explorer to Sell Interest in Nevada Gold Project (12/04/2019)
In the arrangement, the company will garner a 1% net smelter return royalty.
Company Vies for New Brunswick Cannabis Contract (12/04/2019)
The opportunity is one of the largest in retail cannabis in Canada.
Royalty Company Closes Line of Credit Deal with Eric Sprott (12/04/2019)
The $6 million facility is available to the Vancouver-based firm until Nov. 29, 2021.
Cannabis Producer Signs Supply Contract with Province of Alberta (12/04/2019)
To start, the company will introduce its premium brand of dried flower there.
AR Tech Firm Reports Record November Revenue, Gross Profit (12/04/2019)
Increased sales spurred the growth during the month.
Gold Company's Sale of Colombia Project Closes (12/04/2019)
The company will use the proceeds to explore its Nevada asset.
INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously (12/04/2019)
Daniel Carlson of Tailwinds Research initiates coverage on this clinical-stage biotech whose drug candidate works to strengthen the innate immune system.
Protagonist Therapeutics Shares Trade Up 70% on Phase 2 Transfusion Trial Results (12/04/2019)
Newark, Calif.-based Protagonist Therapeutics' shares traded 70% higher today after the firm reported preliminary Phase 2 results for Hepcidin Mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia.
Company Sells Nevada Asset to McEwen Mining, Retains Royalty (12/03/2019)
The transaction is in line with the Vancouver-based company's business model.
AR Firm's Tech Now Integrates with Magento 2.0 E-Commerce Platform (12/03/2019)
The company believes the pairing should multiply the number of online sales that result from an augmented reality component.
'Enormous Mineral Potential' Seen in Montana Mine Site (12/03/2019)
A site visit to this company's project generated optimism in James Kwantes of Resource Opportunities.
Fund Manager's Top Performing Precious Metals Companies for 2019 (12/03/2019)
Ralph Aldis, portfolio manager at U.S. Global Investors, in this interview with Streetwise Reports, looks back at trends in 2019 and looks ahead to what we may expect in the precious metals in 2020; he also discusses the top performers in the precious metals fund that he manages.
Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial (12/03/2019)
Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study.
Vanadium Company Uncovers New Gold Target in Nevada Project (12/03/2019)
First Vanadium CEO Paul Cowley speaks with Peter Epstein of Epstein Research about the state of the vanadium market and his company's plans to explore the newly found gold target on the Carlin Trend in Nevada.
Big Picture Outlook: Seat Belts Tightened (12/02/2019)
Sector expert Michael Ballanger offers his latest insights into the markets and his investment strategy as 2019 winds down.
An Inside Look at Private Placements (12/02/2019)
Sector expert Maurice Jackson begins a four-part series on private placements with a conversation with Tekoa Da Silva of Sprott USA.
Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug (12/02/2019)
Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic eye diseases.
Riverside Resources Takes on New Project in Ontario (12/02/2019)
Freeman Smith, VP of exploration at Riverside Resources, speaks to Maurice Jackson of Proven and Probable about his company's exploration plans for its newest project in Ontario.
Indonesia Rule on Nickel Helps Playfair Mining in Norway (12/01/2019)
Bob Moriarty of 321gold discusses the Indonesian government's actions in the nickel market and how they might affect a company with a project in Norway.
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
|"If LIO can execute, the company can be the next K92."||❭|
|"DV is a story to follow as it embarks on a bigger drill program."||❭|
|"EMO's IBW is in the league of high-quality pre-production projects."||❭|
|"Initial indications from TAO's frack operation are good, on target."||❭|
|"SEA's 1.2% NSR royalty sale removes a significant financing overhang."||❭|